Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China
By Karen Loudon / April 28, 2023
Melbourne, Australia, 28 April 2023 – Cartherics Pty Ltd ("Cartherics"), a biotechnology company developing immune cell therapies for the treatment...
Read More
Cartherics’ offsite provides the opportunity to connect, engage and grow
By Karen Loudon / April 14, 2023
Cartherics recently held a company offsite at the RACV Healesville Country Club and Resort. Nestled in the beautiful Yarra Valley...
Read More
Cartherics proudly supports the White Shirt Campaign
By Karen Loudon / April 11, 2023
Cartherics is hosting a White Shirt Day lunch on 8th May to help raise funds and awareness for ovarian cancer....
Read More
